AI Drug Discovery Startups: Valo Health Remains Committed to AI for Drug Discovery

Lexington-based Valo Health is one of the pioneering players in the AI-drug discovery market. Set up in 2019 as part of Flagship Pioneering’s initiatives, Valo has had quite a roller coaster ride so far.

Featured Videos

AI Drug Discovery Startups: Berg Health Focuses AI on Prostrate Cancer and Parkinsons

The high growth AI-drug discovery market has attracted several players. However, the high cost of drug development, and the slow regulatory process associated with drug release has also led to several consolidations. One such story is that of Berg Health.

AI Drug Discovery Startups: Analysis of Exscientia’s Acquisition by Recursion

A European player looking to make a difference in the high growth AI-drug discovery market is Exscientia. Like others in the industry, it too has had an interesting story. After a brief listing on the stock market, Exscientia was acquired by another AI-based biotech firm Recursion last year.

AI Drug Discovery Startups: Atomwise Focuses on AI-based Small Molecule Discovery

The Small Molecule Drug Discovery Market is estimated to grow at 9% CAGR from $74.08 billion in 2024 to reach $175.41 billion by 2034. San Francisco-based Atomwise is one player that is making use of its AI capabilities to make a mark in the industry.

AI Drug Discovery Startups: Could Insilico Medicine Release the First Drug to be Discovered by AI?

The global artificial intelligence in drug discovery market is projected to grow at 22% CAGR from $1.7 billion in 2023 to reach $11.93 billion by 2033. The healthcare industry is increasingly adopting AI solutions to alleviate the significant financial burdens and potential setbacks that are associated with the drug discovery process. Hong Kong’s InSilico Medicine is one such leading player in the market.

AI Drug Discovery Stocks: Recursion Pharmaceuticals Has a Long Road Ahead

Among the various use-cases for AI, healthcare has been one of the interesting ones. Recursion Pharmaceuticals (NASDAQ: RXRX) is one such notable player in the industry that has successfully leveraged AI in drug discovery.

Exa Wants to be the Google for AI

The increased adoption of AI has led to a surge of new use cases across all industries. One such interesting use-case is being developed by San Francisco-based Exa which is trying build a search engine for AI.

Duolingo Empowers Lily with AI

According to a recent report, the global Online Language Learning Market is estimated to grow 13% over the next few years to reach $16.1 billion by 2032. Online language learning service provider Duolingo (Nasdaq: DUOL) recently announced their quarterly results that surpassed market expectations.

Cloud Stocks: MongoDB Focuses on AI Platform Development

MongoDB (NASDAQ: MDB) reported stellar third quarter results last week. However, sudden leadership changes and worries about a weak sequential growth sent the stock falling 8% in the after-hours session.

Cloud Stocks: Symbotic Leverages AI to Provide Warehousing-as-a-Service

The rise of AI in the recent past has exposed some interesting use-cases across industries. One such example is that of Wilmington, Mass.-based software and robotics maker Symbotic (NASDAQ: SYM), who has successfully leveraged AI to build an offering of Warehouses-as-a-Service.